Canada - English - Health Canada

dominion veterinary laboratories ltd. - ammonium carbonate; potassium bicarbonate; camphor; menthol; squill; buckthorn - liquid - 30.2mg; 52.7mg; 0.44mg; 4.40mg; 0.50mg; 0.70mg - ammonium carbonate 30.2mg; potassium bicarbonate 52.7mg; camphor 0.44mg; menthol 4.40mg; squill 0.50mg; buckthorn 0.70mg - horses; dogs

United States - English - NLM (National Library of Medicine)

pharmaplast sae - capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm) - capsaicin 0.6 mg - topical analgesic temporarily relieves minor pain associated with: - arthritis - simple backache - strains - sprains - bruises - on wounds or damaged skin - with or at the same time as other external analgesic products - conditions worsens - symptoms persist more than 7 days or clear up and occur again within a few days - rash, itching or excessive skin irritation develops

United States - English - NLM (National Library of Medicine)

acorda therapeutics, inc. - capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm) - capsaicin 640 ug in 1 cm2 - qutenza is indicated for the management of neuropathic pain associated with postherpetic neuralgia. none. teratogenic effects: pregnancy category b there are no adequate and well-controlled studies evaluating qutenza in pregnant women. there was no evidence of fetal teratogenicity in embryofetal developmental toxicological studies conducted in pregnant rats and rabbits in which qutenza patches (rats) or liquid (rabbits) were applied once daily for a 3 hour duration during the period of fetal organogenesis up to doses corresponding to an 11-fold (rat, 32 mg capsaicin patch/day) and 37-fold (rabbit, 260 mg capsaicin/day) margin over the maximum recommended human dose [mrhd] based on a c max exposure comparison. in a peri- and post-natal reproduction toxicology study, pregnant female rats were treated with qutenza patches at doses up to 32 mg capsaicin patch/rat/day applied once daily for a 3 hours duration during gestation and lactation (from gestation day 7 through day 28 postpartum). analyses of milk samples

United States - English - NLM (National Library of Medicine)

livcorp inc. - capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm) - capsaicin 0.0375 g in 50 g - capsaicin 0.075%..............topical analgesic for the temporary relief of minor aches and pains of muscles and joints associated with: - simple backache - arthritis - strains - bruises - sprains

United States - English - NLM (National Library of Medicine)

the mentholatum company - capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm) - capsaicin 025 mg - capsaicin - topical analgesic temporarily relieves minor aches and pains of muscles and joints due to - simple backache - arthritis - strains - sprains

Canada - English - Health Canada

wex pharmaceuticals inc - capsaicin - cream - 0.025% - capsaicin 0.025% - basic lotions and liniments

Canada - English - Health Canada

wex pharmaceuticals inc - capsaicin - cream - 0.05% - capsaicin 0.05% - basic lotions and liniments

Canada - English - Health Canada

wex pharmaceuticals inc - capsaicin - cream - 0.075% - capsaicin 0.075% - basic lotions and liniments

Canada - English - Health Canada

ferndale laboratories inc. - capsaicin - cream - .025% - capsaicin .025% - basic lotions and liniments

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - capsaicin 0.25 mg in 1 ml - carefully consider the potential benefits and risks of ibuprofentablets and other treatment options before deciding to use ibuprofen.use the lowest effective dose for the shortest duration consistent withindividual patient treatment goals (see warnings ). ibu tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibu tablets are indicated for relief of mild to moderate pain. ibu tablets are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibu tablets in children have not been conducted. ibu tablets are contraindicated in patients with known hypersensitivityto ibuprofen. ibu tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin orother nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions, and pr